AstraZeneca Halts Lung Cancer Trial for Volrustomig; Reports Positive Data for Tagrisso Combo, Enhertu
MT Newswires -Shutterstock AstraZeneca (AZN.L, AZN.ST) on Monday announced mixed late-stage lung cancer trial results, shuttering its volrustomig…